Testing MK-7262 and Enlicitide for High Lipoprotein(a)
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests two experimental drugs designed to lower lipoprotein(a)—a type of cholesterol particle linked to heart disease—in people whose levels remain high despite taking statins (cholesterol-lowering medications). The goal is to see if these drugs can safely reduce this risk factor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your lipoprotein(a) level must be 150 nmol/L or higher
- You must be taking a stable, optimized dose of statin medication for at least 30 days with no planned changes
- You cannot have a genetic form of high cholesterol (familial hypercholesterolemia)
- You cannot have serious heart conditions, recent heart attacks, strokes, or severe heart rhythm problems
- You cannot have uncontrolled HIV, active hepatitis B or C, severe kidney disease, or uncontrolled diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new medicine called lepodisiran can shrink plaque in heart arteries for adults with high Lp(a) (a type of cholesterol linked to heart disease) who have had a heart event or are at serious risk. The trial uses CT scans to monitor changes in your arteries.
This trial tests an investigational medication, MAR001, to see if it can lower high levels of fats in the blood (triglycerides and remnant cholesterol) linked to heart disease. If you have these conditions, this treatment might help reduce your risk.
This study tests an oral medication called HRS-5346 to see if it can lower a type of fat in the blood called lipoprotein(a), which is linked to heart disease. If you have high Lp(a) and are at risk for heart problems, this trial may help reduce that risk.
This study tests a new daily pill called enlicitide that lowers bad cholesterol in adults at high risk for heart problems. If you have high cholesterol despite being on a statin, this trial could help you manage your cholesterol and reduce your risk of heart attacks or strokes.
This study tests an investigational medicine given by injection to lower Lp(a), a type of fat linked to heart disease. It may help people with high Lp(a) who already have heart problems or are at increased risk.
This study tests an experimental drug (QLC7401) that may help lower LDL ('bad') cholesterol in people who already have high cholesterol or mixed hyperlipidemia. If you're on stable cholesterol medication but still need more lowering, this trial could offer another option.
Hear when a new Lipoprotein(a) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.